Skip to main navigation Skip to search Skip to main content

Design, synthesis, and X-ray crystallographic analysis of a novel class of Hiv-1 protease inhibitors

  • Ashit K. Ganguly
  • , Sesha S. Alluri
  • , Danielle Caroccia
  • , Dipshikha Biswas
  • , Chih Hung Wang
  • , Eunhee Kang
  • , Yong Zhang
  • , Andrew T. McPhail
  • , Steven S. Carroll
  • , Christine Burlein
  • , Vandna Munshi
  • , Peter Orth
  • , Corey Strickland
  • Stevens Institute of Technology
  • Duke University
  • Merck

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Abstract

In the present paper, design, synthesis, X-ray crystallographic analysis, and HIV-1 protease inhibitory activities of a novel class of compounds are disclosed. Compounds 28-30, 32, 35, and 40 were synthesized and found to be inhibitors of the HIV-1 protease. The crucial step in their synthesis involved an unusual endo radical cyclization process. Absolute stereochemistry of the three asymmetric centers in the above compounds have been established to be (4S,2′R,3′S) for optimal potency. X-ray crystallographic analysis has been used to determine the binding mode of the inhibitors to the HIV-1 protease.

Original languageEnglish
Pages (from-to)7176-7183
Number of pages8
JournalJournal of Medicinal Chemistry
Volume54
Issue number20
DOIs
StatePublished - 27 Oct 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Design, synthesis, and X-ray crystallographic analysis of a novel class of Hiv-1 protease inhibitors'. Together they form a unique fingerprint.

Cite this